Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Heng-Chen Chu"'
Autor:
Sandra Phillips, Sameer Mistry, Antonio Riva, Helen Cooksley, Tanya Hadzhiolova-Lebeau, Slava Plavova, Krum Katzarov, Marieta Simonova, Stephan Zeuzem, Clive Woffendin, Pei-Jer Chen, Cheng-Yuan Peng, Ting-Tsung Chang, Stefan Lueth, Robert De Knegt, Moon-Seok Choi, Heiner Wedemeyer, Michael Dao, Chang-Wook Kim, Heng-Chen Chu, Megan Wind-Rotolo, Roger Williams, Elizabeth Cooney, Shilpa Chokshi
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
IFN-lambda (IFNλ) is a member of the type III IFN family and is reported to possess anti-pathogen, anti-cancer, and immunomodulatory properties; however, there are limited data regarding its impact on host immune responses in vivo. We performed long
Externí odkaz:
https://doaj.org/article/dae3934831424155b794e91d52c93b3d
Autor:
Megan Wind-Rotolo, Michael Dao, Pei-Jer Chen, S. Phillips, Moon Seok Choi, Heng Chen Chu, Clive Woffendin, E. Cooney, H. Cooksley, Tanya Hadzhiolova-Lebeau, Shilpa Chokshi, Roger Williams, K. Katzarov, Robert J. de Knegt, Cheng Yuan Peng, Stefan Lueth, Ting-Tsung Chang, Stephan Zeuzem, Slava Plavova, Antonio Riva, Chang Wook Kim, S. Mistry, Heiner Wedemeyer, Marieta Simonova
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Frontiers in Immunology, 8:621. Frontiers Media S.A.
Frontiers in Immunology
Frontiers in Immunology, 8:621. Frontiers Media S.A.
Frontiers in Immunology
IFN-lambda (IFNλ) is a member of the type III IFN family and is reported to possess anti-pathogen, anti-cancer, and immunomodulatory properties; however, there are limited data regarding its impact on host immune responses in vivo. We performed long
Autor:
Phillips, Sandra, Mistry, Sameer, Riva, Antonio, Cooksley, Helen, Hadzhiolova-Lebeau, Tanya, Plavova, Slava, Katzarov, Krum, Simonova, Marieta, Zeuzem, Stephan, Woffendin, Clive, Pei-Jer Chen, Cheng-Yuan Peng, Ting-Tsung Chang, Lueth, Stefan, De Knegt, Robert, Moon-Seok Choi, Wedemeyer, Heiner, Dao, Michael, Chang-Wook Kim, Heng-Chen Chu
Publikováno v:
Frontiers in Immunology; 5/29/2017, p1-13, 13p, 1 Diagram, 3 Charts, 3 Graphs
Publikováno v:
Clinical nuclear medicine. 24(10)
A 70-year-old man with possible pulmonary tuberculosis had taken antituberculosis therapy for 2 months. Dyspnea and abdominal fullness developed and he was found to have acute hepatitis. The antituberculosis drugs were discontinued and his liver enzy